Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC
Clinical trial NCT06537908 · RECRUITING
Trial details
- NCT number
- NCT06537908
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-01
- Primary completion
- 2029-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.